0001144204-12-010570.txt : 20120223 0001144204-12-010570.hdr.sgml : 20120223 20120223143338 ACCESSION NUMBER: 0001144204-12-010570 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120219 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120223 DATE AS OF CHANGE: 20120223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bohai Pharmaceuticals Group, Inc. CENTRAL INDEX KEY: 0001443242 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980588402 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-53401 FILM NUMBER: 12633318 BUSINESS ADDRESS: STREET 1: C/O YANTAI BOHAI PHARMACEUTICALS GROUP STREET 2: NO. 9 DAXIN ROAD, ZHIFU DISTRICT CITY: YANTAI, SHANDONG PROVINCE STATE: F4 ZIP: 264000 BUSINESS PHONE: 86-535-6763559 MAIL ADDRESS: STREET 1: C/O YANTAI BOHAI PHARMACEUTICALS GROUP STREET 2: NO. 9 DAXIN ROAD, ZHIFU DISTRICT CITY: YANTAI, SHANDONG PROVINCE STATE: F4 ZIP: 264000 FORMER COMPANY: FORMER CONFORMED NAME: Link Resources Inc. DATE OF NAME CHANGE: 20080818 8-K 1 v303555_8k.htm 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of Earliest Event Reported): February 23, 2012 (February 19, 2012)

 

Bohai Pharmaceuticals Group, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

000-53401

98-0697405

(State or other jurisdiction
of incorporation)		 (Commission
File Number)

(IRS Employer

Identification No.)

 

 

c/o Yantai Bohai Pharmaceuticals Group Co. Ltd.

No. 9 Daxin Road, Zhifu District

Yantai, Shandong Province, China 264000

(Address of principal executive offices)

 

 

Registrant’s telephone number, including area code: +86(535)-685-7928

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

□Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
□Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
□Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
□Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On February 19, 2012, Adam C. Wasserman notified the Board of Directors (the “Board”) of Bohai Pharmaceuticals Group, Inc. (the “Company”) that he was resigning from the Board, effective on the close of business on February 19. Mr. Wasserman’s resignation was for personal reasons not as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Mr. Wasserman thanked the Board for the opportunity to be of service to the Company.

 

Item 9.01 Financial Statements and Exhibits

 

 (d)Exhibits
   
17.1Letter, dated February 19, 2012, from Adam C. Wasserman to the Company.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

February 23, 2012 Bohai Pharmaceuticals Group, Inc.
   
  By:   /s/ Hongwei Qu
    Name:  Hongwei Qu
    Title:    Chief Executive Officer

 

 

 EX-17.1 2 v303555_ex17-1.htm EXHIBIT 17.1

Exhibit 17.1

 

VIA E-MAIL

 

Letter of Resignation

 

To: The Board of Directors

Bohai Pharmaceuticals Group, Inc.

c/o Yantai Bohai Pharmaceuticals Group Co. Ltd.

No. 9 Daxin Road, Zhifu District

Yantai, Shandong Province, China 264000

 

February 19, 2012

 

Dear Sirs,

 

I hereby resign as a director of Bohai Pharmaceuticals Group, Inc. (the “Company”), with effect

on the close of business on the date hereof.

 

My resignation is for personal reasons and not as a result of any disagreement with the

Company on any matter relating to the Company’s operations, policies or practices.

 

Thank you for the opportunity to be of service to the Company. Best wishes for your continued

success and future endeavors

 

Yours faithfully,

/s/ Adam C. Wasserman

Adam C.Wasserman